Biotech finished on a high in August, according to San Francisco venture capital firm Burrill & Company.
The company’s Burrill Biotech Select Index closed up 4.4 percent on Friday before the Labor Day holiday weekend, said G. Steven Burrill, company CEO.
Top performers included Emeryville’s Onyx Pharmaceuticals (ONXX), up 42 percent, and Vertex Pharmaceuticals, up 21 percent.
